Mission Cancer + Blood

What Mission Cancer + Blood does

Mission Cancer + Blood is an Iowa-based oncology and hematology care provider founded in 1981, operating as a non-profit within University of Iowa Health Care following its December 2024 acquisition for $280 million. The organization delivers medical oncology services, including chemotherapy, immunotherapy, and hematology care, through a network of more than 20 community cancer clinics located across central, western, and southern Iowa, with multiple locations in the Des Moines metro area. It supplements direct care with a portfolio of over 300 cancer clinical trials statewide, genetic counseling services, and holistic cancer support services including financial counseling and support groups.

The organization's core technology and service infrastructure leverages University of Iowa Health Care's NCI Designation status, which is associated with up to 25% greater likelihood of better patient outcomes. Patients access the system through direct appointments, provider referrals, and a digital patient portal (MyChart) that supports scheduling, records access, and care-team communication. The clinical delivery model combines infusion services and oncology treatment with experimental therapy access at the community level, an unusual combination outside academic medical centers.

The business model is healthcare-services revenue: payments come from insurance reimbursements, Medicare, Medicaid, and patient payments, with pricing set by payer agreements rather than public disclosure. The 101-250 employee organization serves cancer patients across Iowa as the sole patient segment, with no disclosed enterprise or B2B contracting channel. Provider referrals function as the principal demand-generation mechanism, supplemented by digital presence on Facebook, LinkedIn, and Instagram and a dedicated web property hosted under UI Health Care.

Name

Mission Cancer + Blood

Legal name

Mission Cancer + Blood

Website

https://missioncancer.com

Company type

Private

Founded year

1981

Operating status

Acquired

Headcount range

101–250 employees

Short description

Mission Cancer + Blood is an Iowa oncology and hematology provider operating 20-plus community cancer clinics across the state, offering treatment, over 300 clinical trials, genetic counseling, and support services as part of University of Iowa Health Care.

Ownership category

akta.pro rank

Product category

Oncology Care Services

NAICS

All Other Outpatient Care Centers (621498), Ambulatory Health Care Services (621)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Medical Oncology (HLAKAFAB)

akta.pro secondary industries

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI), Pediatric Hematology & Oncology (HLAKAFAE), Oncology & Cancer Specialty Hospitals (HLAFAHAC)

Keywords

• Oncology care services
• Cancer treatment clinics
• Hematology care
• Cancer clinical trials
• Genetic counseling services

Headquarters

HQ city

Des Moines

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Healthcare Services Revenue: Healthcare services revenue generated through patient care services including cancer treatment, infusion therapy, clinical trials, and genetic counseling. Revenue is derived from insurance reimbursements, government healthcare programs (Medicare, Medicaid), and patient payments as part of the University of Iowa Health Care system.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Mission Cancer + Blood delivers comprehensive oncology and hematology care through a network of more than 20 community cancer clinics across Iowa, providing cancer treatment, chemotherapy, immunotherapy, infusion therapy, and access to over 300 clinical trials. The organization also offers genetic counseling, cancer support services, and personalized treatment planning, operating as part of the University of Iowa Health Care system with NCI Designation status.

Product overview

Mission Cancer + Blood operates as a unified healthcare platform offering comprehensive oncology services across Iowa. The core offering centers on Mission Cancer + Blood's cancer care services delivered through 20+ community clinics statewide, supplemented by an extensive portfolio of over 300 clinical trials. The platform integrates genetic counseling, personalized treatment options, and holistic support services including financial counseling and support groups. Patients access services through the MyChart portal, which enables appointment scheduling, medical records access, and provider communication. As part of University of Iowa Health Care, the organization leverages NCI designation to deliver research-backed cancer care.

Differentiator

Problem solved

Functional benefit

Products and services

• Oncology Care Services Comprehensive cancer and blood disorder care delivered through more than 20 community cancer clinics across Iowa, offering medical oncology, chemotherapy, immunotherapy, infusion therapy, and personalized treatment plans for patients with various cancer types.
• Cancer Clinical Trials Access to over 300 cancer clinical trials statewide, providing patients with experimental treatment options and cutting-edge therapies across multiple cancer types.
• Genetic Counseling Services Specialized cancer genetics services that assess hereditary risk factors and inform prevention and treatment strategies for patients and families.
• Cancer Support Services Holistic support for cancer patients and their families, including support groups, educational resources, financial counseling services, and treatment handbooks.

Quantifiable outcome

• Patients treated at NCI-designated centers have as much as 25% greater likelihood of better outcomes

Named customers1 record

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• University of Iowa Health CarecoreOthers · 1 December 2024University of Iowa Health Care completed the acquisition of Mission Cancer + Blood in December 2024 for $280 million. Mission Cancer + Blood is now part of UI Health Care, gaining access to expanded resources, NCI designation benefits, and integrated care coordination across the University of Iowa Health Care system.

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Iowa Methodist Medical Center (UnityPoint Health): UnityPoint's flagship Des Moines hospital is a major oncology provider in central Iowa and a primary referral competitor to Mission Cancer + Blood. They offer overlapping medical oncology, infusion, and radiation services in the same metro.
• Tennessee Oncology: Tennessee Oncology operates a multi-site community oncology platform across Tennessee with a large clinical-trial footprint (Sarah Cannon network). It is comparable to Mission in scale, multi-site community delivery, and emphasis on clinical research.
• Minnesota Oncology: Minnesota Oncology is one of the largest independent community oncology practices in the upper Midwest. It mirrors Mission's model — multi-site community clinics, clinical trials, and comprehensive outpatient oncology — and is a comparable peer for benchmarking community-oncology operations.
• Virginia Cancer Specialists: Virginia Cancer Specialists is a large multi-site community oncology and hematology practice, closely paralleling Mission in scope (medical oncology, clinical trials, infusion, genetic counseling). It is a useful outside-Iowa peer for community-oncology comparable practice benchmarks.
• Holden Comprehensive Cancer Center: Holden is the NCI-designated academic cancer center within UI Health Care — Mission's parent system. They are now structurally integrated, share NCI designation, and compete for the same Iowa oncology patients across the academic-community continuum.

Broad incumbents

• OneOncology: OneOncology is a national platform that partners with independent community oncology practices to provide scale, capital, and clinical-trial access — directly comparable to Mission's positioning and increasingly its competitive set as consolidation accelerates.
• US Oncology Network (McKesson): The US Oncology Network is a large national network of community oncology practices under McKesson, focusing on practice support, clinical trials, and value-based care. It is the benchmark incumbent for community-oncology scale and trial throughput.
• City of Hope: City of Hope (which acquired Cancer Treatment Centers of America) is a major NCI-designated specialty oncology system with national reach. It is comparable to Mission's now-amplified NCI-designated oncology footprint, though at much greater scale and specialty focus.
• Mayo Clinic Comprehensive Cancer Center: Mayo's NCI-designated cancer center anchors an academic oncology destination with strong clinical-trial depth. It competes for out-of-state Iowans seeking higher-acuity oncology care and is a logical adjacency for benchmarking trial volume.

Regional players

• McFarland Clinic: McFarland Clinic is the dominant multi-specialty physician group in central Iowa, including oncology and hematology services. It overlaps with Mission's service area and competes for the same Des Moines-area oncology referrals from community physicians.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/Mission-Cancer-Blood
• LinkedInlinkedin.com/company/mission-cancer-blood
• Instagraminstagram.com/missioncancerandblood
• Xx.com/missioncancer

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mission Cancer + Blood